These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 25143382)
1. Structural insights into amyloid oligomers of the Parkinson disease-related protein α-synuclein. Gallea JI; Celej MS J Biol Chem; 2014 Sep; 289(39):26733-26742. PubMed ID: 25143382 [TBL] [Abstract][Full Text] [Related]
3. Structural remodeling during amyloidogenesis of physiological Nα-acetylated α-synuclein. Gallea JI; Sarroukh R; Yunes-Quartino P; Ruysschaert JM; Raussens V; Celej MS Biochim Biophys Acta; 2016 May; 1864(5):501-10. PubMed ID: 26845568 [TBL] [Abstract][Full Text] [Related]
4. Preparation of α-Synuclein Amyloid Assemblies for Toxicity Experiments. Chen SW; Cremades N Methods Mol Biol; 2018; 1779():45-60. PubMed ID: 29886526 [TBL] [Abstract][Full Text] [Related]
5. Phase separation and other forms of α-Synuclein self-assemblies. Poudyal M; Sakunthala A; Mukherjee S; Gadhe L; Maji SK Essays Biochem; 2022 Dec; 66(7):987-1000. PubMed ID: 36373662 [TBL] [Abstract][Full Text] [Related]
6. Direct Correlation Between Ligand-Induced α-Synuclein Oligomers and Amyloid-like Fibril Growth. Nors Perdersen M; Foderà V; Horvath I; van Maarschalkerweerd A; Nørgaard Toft K; Weise C; Almqvist F; Wolf-Watz M; Wittung-Stafshede P; Vestergaard B Sci Rep; 2015 May; 5():10422. PubMed ID: 26020724 [TBL] [Abstract][Full Text] [Related]
7. The role of stable α-synuclein oligomers in the molecular events underlying amyloid formation. Lorenzen N; Nielsen SB; Buell AK; Kaspersen JD; Arosio P; Vad BS; Paslawski W; Christiansen G; Valnickova-Hansen Z; Andreasen M; Enghild JJ; Pedersen JS; Dobson CM; Knowles TP; Otzen DE J Am Chem Soc; 2014 Mar; 136(10):3859-68. PubMed ID: 24527756 [TBL] [Abstract][Full Text] [Related]
8. Structural Characteristics of α-Synuclein Oligomers. Cremades N; Chen SW; Dobson CM Int Rev Cell Mol Biol; 2017; 329():79-143. PubMed ID: 28109332 [TBL] [Abstract][Full Text] [Related]
9. Characterization of heparin-induced glyceraldehyde-3-phosphate dehydrogenase early amyloid-like oligomers and their implication in α-synuclein aggregation. Torres-Bugeau CM; Ávila CL; Raisman-Vozari R; Papy-Garcia D; Itri R; Barbosa LR; Cortez LM; Sim VL; Chehín RN J Biol Chem; 2012 Jan; 287(4):2398-409. PubMed ID: 22134915 [TBL] [Abstract][Full Text] [Related]
10. Structural characterization of toxic oligomers that are kinetically trapped during α-synuclein fibril formation. Chen SW; Drakulic S; Deas E; Ouberai M; Aprile FA; Arranz R; Ness S; Roodveldt C; Guilliams T; De-Genst EJ; Klenerman D; Wood NW; Knowles TP; Alfonso C; Rivas G; Abramov AY; Valpuesta JM; Dobson CM; Cremades N Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E1994-2003. PubMed ID: 25855634 [TBL] [Abstract][Full Text] [Related]
11. α-synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities. Alam P; Bousset L; Melki R; Otzen DE J Neurochem; 2019 Sep; 150(5):522-534. PubMed ID: 31254394 [TBL] [Abstract][Full Text] [Related]
12. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins. Meredith SC Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927 [TBL] [Abstract][Full Text] [Related]
13. Multiparametric fluorescence detection of early stages in the amyloid protein aggregation of pyrene-labeled alpha-synuclein. Thirunavukkuarasu S; Jares-Erijman EA; Jovin TM J Mol Biol; 2008 May; 378(5):1064-73. PubMed ID: 18433772 [TBL] [Abstract][Full Text] [Related]
14. A glimpse into the structural properties of α-synuclein oligomers. Santos J; Pallarès I; Ventura S Biofactors; 2024; 50(3):439-449. PubMed ID: 38063360 [TBL] [Abstract][Full Text] [Related]
15. Defining α-synuclein species responsible for Parkinson's disease phenotypes in mice. Froula JM; Castellana-Cruz M; Anabtawi NM; Camino JD; Chen SW; Thrasher DR; Freire J; Yazdi AA; Fleming S; Dobson CM; Kumita JR; Cremades N; Volpicelli-Daley LA J Biol Chem; 2019 Jul; 294(27):10392-10406. PubMed ID: 31142553 [TBL] [Abstract][Full Text] [Related]
17. Synergistic Amyloid Switch Triggered by Early Heterotypic Oligomerization of Intrinsically Disordered α-Synuclein and Tau. Bhasne K; Sebastian S; Jain N; Mukhopadhyay S J Mol Biol; 2018 Aug; 430(16):2508-2520. PubMed ID: 29704492 [TBL] [Abstract][Full Text] [Related]
18. The N-terminus of α-synuclein is essential for both monomeric and oligomeric interactions with membranes. Lorenzen N; Lemminger L; Pedersen JN; Nielsen SB; Otzen DE FEBS Lett; 2014 Jan; 588(3):497-502. PubMed ID: 24374342 [TBL] [Abstract][Full Text] [Related]
19. The release of toxic oligomers from α-synuclein fibrils induces dysfunction in neuronal cells. Cascella R; Chen SW; Bigi A; Camino JD; Xu CK; Dobson CM; Chiti F; Cremades N; Cecchi C Nat Commun; 2021 Mar; 12(1):1814. PubMed ID: 33753734 [TBL] [Abstract][Full Text] [Related]
20. The status of the terminal regions of α-synuclein in different forms of aggregates during fibrillization. Marvian AT; Aliakbari F; Mohammad-Beigi H; Ahmadi ZA; Mehrpooyan S; Lermyte F; Nasouti M; Collingwood JF; Otzen DE; Morshedi D Int J Biol Macromol; 2020 Jul; 155():543-550. PubMed ID: 32240735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]